The country’s first-ever clinical testing of mesenchymal stem cell transplants will soon begin at China Medical University Hospital (CMUH) in Taichung after the project was approved by the Department of Health, hospital researchers said yesterday.
The project is one of a number of clinical experiments involving stem cells conducted by Bionet — a Taiwan-based biotech company — and sponsored by the Ministry of Economic Affairs.
Following the mesenchymal stem cell transplant tests, five other projects will be conducted at other hospitals.
Wu Kang-hsi (巫康熙), a CMUH physician who will supervise the testing, said the project would determine whether mesenchymal stem cells can help transplanted umbilical blood stem cells treat diseases related to malfunctioning hematopoietic stem cells, such as leukemia and thalassemia.
Mesenchymal stem cells are a type of multipotent stem cell that can differentiate into various cells, including pancreatic islet cells and neuronal cells.
Unlike most other adult stem cells, mesenchymal stem cells can be obtained in quantities needed for clinical applications. They can also be maintained for long periods of time without losing their capacity to form different cell types.
Wu said that although umbilical blood stem cells have proven effective in repairing tissue and treating blood-related diseases, their efficiency is sometimes limited because only a small amount of the cells can be collected from umbilical blood and the cells tend to reproduce at slow rates after transplant operations.
“Some past experiments on animals suggested that when assisted by additional mesenchymal stem cells, the umbilical blood stem cells may be able to work twice as fast,” Wu said. “For this project, we aim to determine whether the results are the same for humans.”
Wu said the project at CMUH would last a year and include tests on at least 10 volunteers.
Alain Robert, known as the "French Spider-Man," praised Alex Honnold as exceptionally well-prepared after the US climber completed a free solo ascent of Taipei 101 yesterday. Robert said Honnold's ascent of the 508m-tall skyscraper in just more than one-and-a-half hours without using safety ropes or equipment was a remarkable achievement. "This is my life," he said in an interview conducted in French, adding that he liked the feeling of being "on the edge of danger." The 63-year-old Frenchman climbed Taipei 101 using ropes in December 2004, taking about four hours to reach the top. On a one-to-10 scale of difficulty, Robert said Taipei 101
Nipah virus infection is to be officially listed as a category 5 notifiable infectious disease in Taiwan in March, while clinical treatment guidelines are being formulated, the Centers for Disease Control (CDC) said yesterday. With Nipah infections being reported in other countries and considering its relatively high fatality rate, the centers on Jan. 16 announced that it would be listed as a notifiable infectious disease to bolster the nation’s systematic early warning system and increase public awareness, the CDC said. Bangladesh reported four fatal cases last year in separate districts, with three linked to raw date palm sap consumption, CDC Epidemic Intelligence
Two Taiwanese prosecutors were questioned by Chinese security personnel at their hotel during a trip to China’s Henan Province this month, the Mainland Affairs Council (MAC) said yesterday. The officers had personal information on the prosecutors, including “when they were assigned to their posts, their work locations and job titles,” MAC Deputy Minister and spokesman Liang Wen-chieh (梁文傑) said. On top of asking about their agencies and positions, the officers also questioned the prosecutors about the Cross-Strait Joint Crime-Fighting and Judicial Mutual Assistance Agreement, a pact that serves as the framework for Taiwan-China cooperation on combating crime and providing judicial assistance, Liang
US climber Alex Honnold left Taiwan this morning a day after completing a free-solo ascent of Taipei 101, a feat that drew cheers from onlookers and gained widespread international attention. Honnold yesterday scaled the 101-story skyscraper without a rope or safety harness. The climb — the highest urban free-solo ascent ever attempted — took just more than 90 minutes and was streamed live on Netflix. It was covered by major international news outlets including CNN, the New York Times, the Guardian and the Wall Street Journal. As Honnold prepared to leave Taiwan today, he attracted a crowd when he and his wife, Sanni,
RSS